Who is sponsoring NCT05624372?

NCT05624372 is sponsored by Sheba Medical Center.

What drugs are being tested in NCT05624372?

Interventions in NCT05624372: hearing and cognitive assessment.

What condition does NCT05624372 study?

NCT05624372 studies no Conditions.

Is NCT05624372 still recruiting?

NCT05624372 is currently recruiting now. Last updated 21 May 2024.

Last reviewed 2024-05-21 · How we verify

NCT05624372: ME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Speech Perception in Noise in Children With ADHD

Recruiting now Last updated 21 May 2024

What this trial tests

trial testing hearing and cognitive assessment in no Conditions in 100 participants. Currently enrolling.

Timeline

22 May 2018

Primary endpoint
30 March 2025

30 March 2025

Quick facts

Lead sponsor	Sheba Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	22 May 2018
Primary completion	30 March 2025
Estimated completion	30 March 2025
Sites	1 location across Israel

Drugs / interventions tested

hearing and cognitive assessment

Conditions studied

no Conditions — all drugs for no Conditions →

Sponsor

Sheba Medical Center

Who can join

Adults 4 to 18, any sex, with no Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We are going to assess an ability of speech perception in voice in children diagnosed with ADHD (Attention Deficit Hyperactivity Disorder), comparing to normal control group. This is an attempt to understand the factors influencing on this ability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sheba Medical Center trials

Trials by the same sponsor.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07523373 — Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch · NA · not yet recruiting
NCT07509229 — 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients · Phase 1, PHASE2 · not yet recruiting
NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05624372 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheba Medical Center
Last refreshed: 21 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05624372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing